Thormann, M., Heitmann, F., March, C., Pech, M., Hass, P., Surov, A., . . . Omari, J. (2022). Sarcopenia does not limit overall survival after interstitial brachytherapy for breast cancer liver metastases. Journal of Contemporary Brachytherapy, 14(4), 364. https://doi.org/10.5114/jcb.2022.119515
Chicago Style (17th ed.) CitationThormann, Maximilian, Franziska Heitmann, Christine March, Maciej Pech, Peter Hass, Alexey Surov, Robert Damm, and Jazan Omari. "Sarcopenia Does Not Limit Overall Survival After Interstitial Brachytherapy for Breast Cancer Liver Metastases." Journal of Contemporary Brachytherapy 14, no. 4 (2022): 364. https://doi.org/10.5114/jcb.2022.119515.
MLA (9th ed.) CitationThormann, Maximilian, et al. "Sarcopenia Does Not Limit Overall Survival After Interstitial Brachytherapy for Breast Cancer Liver Metastases." Journal of Contemporary Brachytherapy, vol. 14, no. 4, 2022, p. 364, https://doi.org/10.5114/jcb.2022.119515.